Pharma Capsules - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Pharma Capsules
News and Views

Pharmaceutical Technology


IPR to Service Manesty Machines

Manesty (Fairfield, NJ, announced that IPR Inc. (Bartlett, IL, will undertake all original equipment manufacturer (OEM) service work for Manesty's tablet presses and coaters in North America. IPR has experience servicing, repairing, and rebuilding Manesty tablet presses to clients' standards. Through IPR, Manesty will offer direct OEM service to all its North American customers.


GE Acquires Wave Biotech

GE Healthcare (Chalfont St.Giles, UK, acquired Wave Biotech (Somerset, NJ,, a supplier of disposable manufacturing technologies for the biopharmaceutical industry. The acquisition includes Wave Biotech's subsidiary, Wave Europe, and will allow GE Healthcare to expand its offering of products and services for the manufacture of biopharmaceuticals such as antibodies and vaccines. Financial terms were not disclosed.

Bosch to Buy Pharmatec

The Bosch Group (Stuttgart, Germany, plans to acquire Pharmatec GmbH (Dresden, Germany,, from Fresenius ProServe GmbH. The transaction will include Pharmatec's subsidiary Schoeller-Bleckmann Medizintechnik Ges.m.b.H, headquartered in Ternitz, Austria.

Bosch develops and manufactures process and packaging machinery for the pharmaceutical industries. Pharmatec focuses on hygienic and aseptic process technologies for the pharmaceutical and biotechnology industries.The purchase price was not disclosed, and the transaction is subject to approval by antitrust authorities.


AdvantaPure Names Director of Software Solutions

AdvantaPure (Southampton, PA, promoted Jeffrey D. Johnson to the new position of director of software solutions. Johnson's focus will be on AdvantaPure's line of radio-frequency identification (RFID) tracking products, including "GammaTag," the company's gamma-sterilizable RFID tag. His new duties include developing, installing, and supporting the company's RFID products.

Johnson previously was Advantapure's network administrator. He joined NewAge Industries, AdvantaPure's parent company, in 1990 as a sales representative.

IPS Announces Appointments

Integrated Project Services (IPS, Lafayette Hill, PA,, an engineering firm serving the pharmaceutical and biotechnology industries, appointed Eugene K.Martini senior director, projectdelivery operations. In this role, Martini will oversee the daily operations of that division.He has been involved with manufacturing and development projects regulated by the US Food and Drug Administration for the past 15 years. Martini recently worked at CDI Corporation as director of project management.

IPS also appointed David J. Brown director, project services. Brown will lead the project-services and project-controls teams to develop solutions to support client projects and business objectives. He will also implement various project-controls functions such as estimating, planning, cost control, change management, progress measurement, risk management, and cashflow projections for pharmaceutical and biopharmaceutical clients.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here